Sign In
Buy PCRX
$26.41
-0.560 (-2.08%)
At Close: Jul 31, 2026
Pacira BioSciences to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
08:05pm, Wednesday, 05'th Aug 2020
PARSIPPANY, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will present at the 2020 Wedbush PacGrow Healthcare Virtual Conference at 9:10 AM E
Pacira Announces Publication of Phase 4 Study of EXPAREL in Cesarean Section Procedures in Anesthesia & Analgesia
11:30am, Wednesday, 05'th Aug 2020
– Results show an opioid-reducing benefit of adding EXPAREL to bupivacaine transversus abdominis plane (TAP) blocks for cesarean delivery –PARSIPPANY, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Pacir
Pacira BioSciences Announces FDA Acceptance of sNDA for EXPAREL Use in Pediatric Patients
11:30am, Tuesday, 04'th Aug 2020
sNDA submission based on positive Phase 3 data supporting expansion of the EXPAREL label to include use in children aged six and overPARSIPPANY, N.J., Aug. 04, 2020 (GLOBE NEWSWIRE) -- Pacira BioScien
Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020
11:30am, Thursday, 30'th Jul 2020
PARSIPPANY, N.J., July 30, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets
The Daily Biotech Pulse: Merck's Breakthrough Therapy Designation, Sonoma Surges On Sanitizer News, Sanofi-Glaxo And More
12:00am, Wednesday, 29'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 28)
Axonics Modulation Technologies Inc (NASDAQ: AXNX)
Capricor Therapeutics Inc (NASDAQ: CAPR)
Fulgent Genetics Inc...
Pacira BioSciences Announces Settlement of Government Investigation
09:03pm, Tuesday, 28'th Jul 2020
Pacira to Pay $3.5 Million to Settle Various Claims with No Admission of WrongdoingPARSIPPANY, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of in
State Street Corp Grows Position in Pacira Biosciences Inc (NASDAQ:PCRX)
07:00am, Tuesday, 21'st Jul 2020
State Street Corp grew its stake in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 5.6% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 1,403,659 shares of the com
Brokerages Expect Pacira Biosciences Inc (NASDAQ:PCRX) Will Announce Quarterly Sales of $75.50 Million
01:20am, Sunday, 19'th Jul 2020
Equities research analysts expect Pacira Biosciences Inc (NASDAQ:PCRX) to post $75.50 million in sales for the current quarter, according to Zacks. Four analysts have provided estimates for Pacira Bio
Royal Bank of Canada Boosts Stock Holdings in Pacira Biosciences Inc (NASDAQ:PCRX)
05:13am, Saturday, 18'th Jul 2020
Royal Bank of Canada grew its stake in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 73.7% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fi
Ocular Therapeutix Presents at the 12th Annual Ophthalmology Innovation Summit (OIS)
12:00am, Friday, 17'th Jul 2020
Ocular Therapeutix, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative ther
Pacira Biosciences (NASDAQ:PCRX) Reaches New 12-Month High on Analyst Upgrade
01:18am, Tuesday, 14'th Jul 2020
Pacira Biosciences Inc (NASDAQ:PCRX)’s share price hit a new 52-week high during mid-day trading on Monday after Jefferies Financial Group raised their price target on the stock from $53.00 to $69.0
Pacira Biosciences (NASDAQ:PCRX) Earns “Buy” Rating from HC Wainwright
08:58am, Monday, 13'th Jul 2020
Pacira Biosciences (NASDAQ:PCRX)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a note issued to investors on Monday, The Fly reports. They presently have a $
Two Sigma Advisers LP Sells 47,800 Shares of Pacira Biosciences Inc (NASDAQ:PCRX)
07:40am, Sunday, 12'th Jul 2020
Two Sigma Advisers LP cut its holdings in shares of Pacira Biosciences Inc (NASDAQ:PCRX) by 85.2% during the first quarter, Holdings Channel.com reports. The firm owned 8,276 shares of the company’s
Did Hedge Funds Make The Right Call On Pacira Biosciences Inc (PCRX)?
11:02pm, Saturday, 11'th Jul 2020
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that sm
The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
12:00am, Friday, 10'th Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 9)
Affimed NV (NASDAQ: AFMD)...
